from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1895/-

LFCtreatmentdescriptionclass of inhibitor

1.579

Amikacinug/mL Amikacintranslation

1.281

Cap5-10ug/mL Capreomycintranslation

2.260

Rox10-50 ug/mL Roxithromycintranslation

0.690

SM2-5 ug/mL Streptomycintranslation

2.064

Tet5-10 ug/mL Tetracyclinetranslation

0.738

Rif0.2-5ug/mL Rifampicintranscription

-0.061

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.149

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.794

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.579

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.099

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.070

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.887

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.868

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.022

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.372

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.526

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.900

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.134

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.848

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.107

KCN5-20 ug/mL Potassium cyaniderespiration

-0.206

NaN30.2-2 mM Sodium aziderespiration

-0.092

Nigericin50 uM Nigericinrespiration

-0.057

TRC10-150 ug/mL Triclosanrespiration

0.036

TRZ10-25 ug/mL Thioridazinerespiration

1.111

Valinomycin0.5-10 uM Valinomycinrespiration

0.352

ZnSO42 mM ZnSO4respiration

0.226

menadione6-10 ug/mL Menadionerespiration

0.795

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.066

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.559

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.431

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.966

NRP_1Non-replicating persistence stage 1dosRassociated

-0.398

Amp0.2mg/mL AmpicillincellWall

-0.244

Cephalexin20-100 ug/mL CephalexincellWall

-0.411

Cerulenin0.32-5 ug/mL CerulenincellWall

0.838

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.004

EMB10-20 ug/mL EthambutolcellWall

-0.590

Eta12-40 ug/mL EthionamidecellWall

-0.335

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.363

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.504

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.495

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.020

BZA0.12 mg/mL BenzamidearomaticAmides

0.188

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.626

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.200

H2O24 mM hydrogen peroxideDNAdamaging

-0.158

Levo10 ug/mL LevofloxacinDNAdamaging

-0.093

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.302

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.194

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.598

UVUV-irradiationDNAdamaging

-0.237

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.090

Antimycin12.5-50 ug/mL Antimycin A?

0.014

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.169

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.065

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.177

PA8240.2-2 ug/mL PA-824?

-0.927

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.542

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.186

Verapamil50 uM Verapamil?

0.829

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.055

methoxatin10-20 ug/mL Methoxatin?